date,title,source
Oct-19-18,"Research Report Identifies Brookfield Asset Management, Becton, Dickinson, IPG Photonics, ASML Holding N.V, American National Insurance, and Madrigal Pharmaceuticals with Renewed Outlook  Fundamental Analysis, Calculating Forward Movement",GlobeNewswire
Nov-06-18,Madrigal Pharmaceuticals Reports 2018 Third Quarter Financial Results and Highlights Upcoming Clinical Events,GlobeNewswire
Nov-12-18,Madrigal preparing for late-stage testing of experimental NASH treatment,American City Business Journals
Nov-14-18,"Better NASH Stock: Madrigal Pharmaceuticals, Inc. vs. Viking Therapeutics, Inc.",Motley Fool
Nov-19-18,"Madrigal Pharmaceuticals Inc (MDGL) CEO Paul A Friedman Bought $496,000 of Shares",GuruFocus.com
Nov-19-18,"Viking Has A More Attractive M&A Valuation Than Madrigal, Raymond James Says In Upgrade",Benzinga
Nov-23-18,"Madrigal Pharmaceuticals Inc (MDGL) CEO Paul A Friedman Bought $471,520 of Shares",GuruFocus.com
Nov-28-18,"Report: Exploring Fundamental Drivers Behind CASI Pharmaceuticals, Booking, Enstar Group, Madrigal Pharmaceuticals, Dermira, and Kaiser Aluminum  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
